Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | FNTA | P49354 | 3/20 | 0.44 |
| ▸ | FNTB | P49356 | 3/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.43 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29720364 | 1.00 | ALDH1A1 (0.52) | ALDH1A1ALOX15FNTAFNTBTRPV1 | |
| SCHEMBL5596597 | 0.86 | ALDH1A1 (0.69) | ALDH1A1ALOX15FNTAFNTBTRPV1 | |
| SCHEMBL874196 | 0.86 | ALDH1A1 (0.69) | ALDH1A1ALOX15FNTAFNTBTRPV1 | |
| SCHEMBL1793466 | 0.86 | ALDH1A1 (0.69) | ALDH1A1ALOX15FNTAFNTBTRPV1 | |
| SCHEMBL18604017 | 0.86 | ALDH1A1 (0.69) | ALDH1A1ALOX15FNTAFNTBTRPV1 | |
| SCHEMBL874195 | 0.86 | ALDH1A1 (0.69) | ALDH1A1ALOX15FNTAFNTBTRPV1 | |
| SCHEMBL29165442 | 0.85 | ALDH1A1 (0.67) | ALDH1A1ALOX15FNTAFNTBTRPV1 | |
| SCHEMBL5869130 | 0.85 | ALDH1A1 (0.67) | ALDH1A1ALOX15FNTAFNTBTRPV1 | |
| SCHEMBL5506863 | 0.83 | FNTA (0.54) | ALDH1A1ALOX15FNTAFNTB | |
| SCHEMBL30136431 | 0.82 | ALDH1A1 (0.55) | ALDH1A1ALOX15FNTAFNTBTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11944727-B2 | Air freshening device | GIVAUDAN SA (CH) | 2024-04-02 | — | — | US | disclosed |
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-02-08 | — | — | US | disclosed |
| EP-4288022-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2023-12-13 | — | — | EP | disclosed |
| WO-2022167123-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2022-08-11 | — | — | WO | disclosed |
| EP-4039244-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2022-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | AOX1, TYR, OCIAD1 | ALDH1A1 116/4885ALOX15 158/4885FNTA 1409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.